GleanMark

TRIPLEX Trademark

TRIPLEX is a USPTO trademark filed by Selectpharma, S.A.. Status: Pending.

Prosecution Summary

Trademark Summary
The stylized mark TRIPLEX, featuring the word in bold font inside a left-positioned ellipse on a dotted grid background, covers pharmaceutical goods in International Class 005 such as topical analgesic creams, anti-inflammatory and antibiotic ointments, burn relief medications, and skin preparations to prevent chafing, along with classes 006, 018, 044, 046, 051, and 052. It is owned by Selectpharma, S.A., a Guatemalan corporation. The application is suspended due to a post-publication opposition. An opposition (No. 91305095) filed by Cory Laboratories, Inc. is pending before the TTAB and was suspended on February 19, 2026, pending settlement negotiations.

Recent Activity
Filed August 13, 2025, the application received a non-final office action

Trademark Facts

MarkTRIPLEX
Serial Number99335962
StatusPending
Filing Date2025-08-13
Mark TypeCombined
Nice Classes005 (Pharmaceuticals)
OwnerSelectpharma, S.A.
Attorney of RecordTORE T. DEBELLA
Prosecution Events22
Latest EventOP.I on 2026-02-11

Goods & Services

Topical analgesic creams; Anti-inflammatory ointments; Anti-itch ointment; Medicated ointments for treating dermatological conditions; Antibiotic ointments; Burn relief medication; Preparations for the treatment of burns; Sports cream for relief of pain; Preparation for the relief of pain; Medicated diaper rash ointments and lotions; Skin lubricants for athletes to prevent skin chafing; Antifungal creams for medical use; Antifungal preparations; Anti-friction skin preparations for preventing chafing; Lubricating skin preparations for the prevention of chafing; Topical preparations, namely, creams and ointments

Recent Prosecution Activity

DateDocumentType
2026-01-16Amendment and Mail Process CompleteAMC
2026-01-15Change Address or Representation FormCAR
2026-01-13OG Publication ConfirmationPB3
2026-01-07Notification of Notice of PublicationEB4
2026-01-07Notice of PublicationPB1
2025-12-16Amendment and Mail Process CompleteAMC

USPTO Refusals on Record

Related